Official UK visa sponsor profile for Artios Pharma Limited in Cambridge, including current register status, route details, and public company data.
Artios Pharma Limited, registration number 09931309, is an active limited company established in 2015 and based at Babraham Hall, Babraham Research Campus, Cambridge, CB22 3AT, England-Wales. The company operates as an independent research and experimental development company focused on biotechnology, specifically with a key focus on Damage and Repair (DDR) mechanisms in cancer therapies. According to website information, Artios Pharma is classified as an independent company. Its services center around the development of novel cancer therapies, with potential for first-in-class and best-in-class treatments. The company does not currently have an international presence and exhibits no hiring activity. Financial records indicate accounts were prepared for the period ending 2024-12-31, with no recorded charges and the company is not insolvent. The company holds a Skilled Worker visa and a Worker (A rating). Artios Pharma Limited is engaged in research and development, utilizing the Babraham Research Campus as its operational base. The company’s strategic direction is centered on DDR pathways within cancer biology.
This summary is AI-generated from public sources (Companies House, the company website, and the official sponsor register) and may not be fully accurate or current. Verify important details against the official Home Office register or the company's own website.
Official UK visa sponsor profile for Artios Pharma Limited in Cambridge, including current register status, route details, and public company data.
Artios Pharma Limited, registration number 09931309, is an active limited company established in 2015 and based at Babraham Hall, Babraham Research Campus, Cambridge, CB22 3AT, England-Wales. The company operates as an independent research and experimental development company focused on biotechnology, specifically with a key focus on Damage and Repair (DDR) mechanisms in cancer therapies. According to website information, Artios Pharma is classified as an independent company. Its services center around the development of novel cancer therapies, with potential for first-in-class and best-in-class treatments. The company does not currently have an international presence and exhibits no hiring activity. Financial records indicate accounts were prepared for the period ending 2024-12-31, with no recorded charges and the company is not insolvent. The company holds a Skilled Worker visa and a Worker (A rating). Artios Pharma Limited is engaged in research and development, utilizing the Babraham Research Campus as its operational base. The company’s strategic direction is centered on DDR pathways within cancer biology.
This summary is AI-generated from public sources (Companies House, the company website, and the official sponsor register) and may not be fully accurate or current. Verify important details against the official Home Office register or the company's own website.
Yes, Artios Pharma Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Artios Pharma Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Artios Pharma Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Artios Pharma Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.